NEWARK, Del, May 08, 2023 (GLOBE NEWSWIRE) -- The phospholipid market is predicted to be valued at US$ 1.55 Billion in 2023 and US$ 4.64 Billion by 2033. Over the projection period, sales of ...

Scientists have gained a deeper understanding of a molecule that regulates lipid levels in the brain. This breakthrough could eventually lead to treatments for diseases like frontotemporal dementia ...

The relationship of the oxidized phospholipid:apo B-100 ratio and Lp (a) lipoprotein levels to coronary artery disease remained fundamentally similar after the exclusion from analysis of 41 ...

The antiphospholipid syndrome is an autoimmune disorder of hypercoagulability characterized by the presence of autoantibodies to various phospholipids or phospholipid-binding proteins. The autoanti ...

Phosphatidylserine is a greasy substance known as a phospholipid. Every single cell in your body produces phosphatidylserine. The phospholipid helps protect and cover cells from attackers. Your ...

The phospholipid, or lecithin, found in egg markedly inhibits the cholesterol absorption. The inhibition is not 100 per cent, he said. Some cholesterol is absorbed but the amount is significantly ...

Medically important phospholipids are observed in cellular condensates. [Top] PIP 2 (green), a phospholipid involved in cell signaling, is observed in nuclear speckle condensates (red). [Bottom ...

Phosphatidylserine (PtdSer) is a phospholipid that is abundant in eukaryotic plasma membranes. An ATP-dependent enzyme called flippase normally keeps PtdSer inside the cell, but PtdSer is exposed ...

A liposome is a spherical-shaped vesicle that is composed of one or more phospholipid bilayers, which closely resembles the structure of cell membranes. The ability of liposomes to encapsulate ...

In autoimmune diseases, the immune system wrongly identifies its “enemy”, and produces antibodies that attack the patient’s own cells. One of these diseases, the anti-phospholipid antibody ...

In autoimmune diseases, the immune system wrongly produces antibodies that attack the patient's own cells. One of these diseases, anti-phospholipid antibody syndrome (APS), is still poorly ...